GTC Biotherapeutics (fka GTCB)

[Lewis R Goudy]

>Just how different structurally is Atryn from the naturally occurring human protein?<

They are sequentially identical, with some glycoconditioned
differences in pharmacokinetics. The need for clinical
address stems less from those differences than validation
of manufacturing process.